it   en   de 

Company Diagnostics Oncology Orthopaedic Information

last update: 03-09-2010
News

iClin Solutions, An IGEA Partner, Launch New Therapy For Cancer Treatment
iClin Solutions AB, a supplier of intelligent solutions for cancer treatment and IGEA partner in Sweden, today announced the launch of Electro Chemo Therapy – ECT – and the first treatment using the Cliniporator in Sweden. The Cliniporator device has been developed and is manufactured by IGEA (Carpi, Italy).
The treatment was performed at the Department of Oncology at Lund University Hospital under the supervision of Dr. Julie Gehl from Herlev Hospital in Denmark.
“We are very happy to offer the latest technology in cancer treatment. The Cliniporator treats cancer of any histological type in a quick and efficient manner” says Anders Johnsson, Managing Director of iClin Solutions. He continues: “We are currently focusing our resources on successful introduction to other clinics in Northern Europe.”
“ECT is exciting and will become a standard option in Lund, offering great alternative to some of our patients” says Jacob Engellau, Director for Radiation Therapy at the Oncology department in Lund. Together with Dr. Per Engström, Medical Physicist, he plays an important part of the introduction in Lund.
The Cliniporator is used to fight cutaneous and sub-cuteaneous metastasies by increasing the effect of chemotherapeutic drugs offering a very good alternative to traditional radiation therapy and surgery.
“Not only will the device increase the effect of these drugs, it also requires a much
smaller dose, minimizing the risk of complications” says Anders Johnsson. Since the treatment can be done on an out-patient basis, it also offers cost savings compared to radiation therapy or surgery.
The drug used in most of the treatments is bleomycin, a well-known drug in oncology. It is highly effective and toxic, killing the cancer cells once it has entered the cells. However, due to its large size, it cannot enter through the cell membrane by itself and has been considered inefficient.
With the combination of electroporation, this drug has now become a very effective anti-cancer drug. Electroporation temporarily opens up small pathways (pores) in the cell membrane barrier by using very brief, intense electrical pulses.
Dr Julie Gehl is a Clinical Associate Research Professor at the Department of Oncology at Copenhagen University Hospital Herlev. Dr. Gehl has been instrumental in the clinical research and launch of the Cliniporator and the ECT therapy in Europe.




11-06-2010 Electrochemotherapy: Alessandro Testori of IEO presents the latest results [Oncology]
29-05-2010 Local treatment of primary breast carcinoma by electrochemotherapy [Oncology]
08-04-2010 Bone metastases: electric fields to bring drugs into tumour cells [Igea]
03-11-2009 IGEA partner del il ?Progetto Salute Donna? per prevenire l?osteoporosi [Diagnostics]
23-10-2009 Cork Cancer Research Centre: a decade of delivery [Oncology]
28-07-2009 Best wishes to IGEA GmbH (Munich, Germany) [Igea]
04-05-2009 IGEA apre le porte ai professionisti del mondo sanitario [Igea]
08-04-2009 IGEA al XXIV° Congresso Nazionale SIDCO [Oncology]
08-04-2009 Proteggere la cartilagine articolare con I-ONE Terapia [Orthopaedic]
23-10-2008 Electrochemotherapy for chest wall recurrence of breast cancer: present challenges and future prospects [Oncology]
10-08-2008 Thanks to Matteo Tagliariol [Orthopaedic]
14-05-2008 A prize for Cliniporator at National UK Cancer Conference [Oncology]
05-05-2008 iClin Solutions, An IGEA Partner, Launch New Therapy For Cancer Treatment [Oncology]
14-03-2008 La prevenzione dell'osteoporosi in giovani calciatrici con DBM Sonic BP [Diagnostics]
14-03-2008 IGEA offre il proprio supporto all'associazione O.N.Da per la prevenzione dell'osteoporosi. [Igea]
14-03-2008 Osteoporosi, una patologia ancora sotto-diagnosticata [Diagnostics]
12-03-2008 Elettrochemioterapia: una valida soluzione per le metastasi cutanee e sub cutanee [Oncology]
12-03-2008 Osteoartrite e traumi cartilaginei oggi curati con terapie specifiche, senza controindicazioni [Orthopaedic]
15-01-2008 Studi clinici attestano l'efficacia della terapia I-ONE. [Orthopaedic]
15-01-2008 Un nuovo progetto per rendere sempre più efficace l'elettrochemioterapia e aiutare il paziente oncologico. [Oncology]
15-12-2007 Terapie su misura con i dispositivi medici IGEA. [Igea]
22-10-2007 IGEA premia l'impegno nella ricerca e sviluppo. [Igea]
15-10-2007 Sonic Bone Profiler: un valido strumento di misura dello stato di salute dell'osso. [Diagnostics]
10-10-2007 I-ONE, il nuovo sistema terapeutico per proteggere le articolazioni. [Igea]
20-09-2007 IGEA, da più di 25 anni al servizio della biofisica clinica. [Igea]
14-09-2007 Antonietta Di Martino, un volo d'argento [Igea]
30-08-2007 Igea presents Imaging Equipment, a new partner in United Kingdom. [Oncology]
29-08-2007 Dr G Gualdi (Modena, Italy) won the "Poster Award" at the EADV conference [Oncology]
10-06-2007 Communication on clinical trial on SECTA [Igea]
08-06-2007 Igea announces: Cliniporator&trade technology is patent protected worldwide [Igea]
07-05-2007 Surse: Repubblica Salute, 31 Maggio 2007 [Diagnostics]
07-05-2007 Igea presents iClin, a new partner in Northern Europe. [Oncology]
07-05-2007 The I-ONE CRES Study won the Award of Excellence by the AAOS [Orthopaedic]
20-03-2007 A dedicated Issue of the European Journal of Cancer Supplements to Electrochemotherapy. [Oncology]


Filtra per categoria:



 
Home    |    Company   |    Diagnostics    |    Oncology   |    Orthopaedic   |    Information   |    Site map
 
IGEA © 2007 | Privacy Policy | Credits | Italiano | English | Deutsche
 
IGEA S.p.A. Via Parmenide, 10/A - 41012 CARPI (MO) ITALY
C.F. e P.I. 01021130362 – Capitale Sociale € 163.450,00 i.v. - REA 205183 - Reg. Soc. Trib. 14968 - Iscritto nelle imprese di Modena